Retraction notice to “A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design” [Mech. Ageing Dev. 213 (2023) 111825]
Titel:
Retraction notice to “A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design” [Mech. Ageing Dev. 213 (2023) 111825]
Auteur:
Davidy, Tal Yore, Iscka Cukierman-Yaffe, Tali Ravona-Springer, Ramit Livny, Abigail Lesman-Segev, Orit H. Azuri, Yossi Carmichael, Owen Kapogiannis, Dimitrios Zetterberg, Henrik Lin, HungMo Sano, Mary Beeri, Michal Schnaider